About
David is a principal associate in our corporate/M&A team and part of our global transactions group.
He advises financial sponsors and corporations on domestic and cross-border M&A transactions.
David speaks German and English.
Additional Information
- Klocke Group and IDT Biologika on strategic partnership with SK bioscience
- One Equity Partners on the sale of Walki to Oji Holdings Corporation
- One Equity Partners on the acquisition of Fortaco group from CapMan Buyout
- International Chemical Investors Group on the sale of Corden Pharma to Astorg
- Corden Pharma on the acquisition of three production sites from Vifor Pharma
- Lindsay Goldberg on the sale of PACCOR group to Faerch group
- One Equity Partners on the sale of Lutech to Apax
- One Equity Partners on the acquisition of a 29% stake in Cicor Technologies AG from HEB Swiss Investment AG
Dr. David Anschütz
Principal Associate
T +49 69 27 30 80
frankfurt am main Office
Bockenheimer Anlage 44
60322 frankfurt am main